Estetrol/Drospirenone to Reduce the Average Size of Endometriomas

NCT05837624 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Endometrioma
Endometrioma

Interventions

DRUG: Estetrol/Drospirenone

Sponsor

Andrew Zakhari